HI
EW icon

Humankind Investments’s Edwards Lifesciences EW Stock Holding History

Humankind Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,248
Closed -$564K – 74
2025
Q3 		$564K Buy
7,248
+283
+4% +$22.1K 0.13% 82
2025
Q2 		$545K Buy
6,965
+506
+8% +$37.7K 0.13% 82
2025
Q1 		$468K Sell
6,459
-513
-7% -$36.7K 0.12% 90
2024
Q4 		$516K Buy
6,972
+473
+7% +$33.1K 0.13% 85
2024
Q3 		$429K Buy
6,499
+1,724
+36% +$125K 0.15% 88
2024
Q2 		$441K Buy
4,775
+925
+24% +$81.9K 0.12% 88
2024
Q1 		$368K Sell
3,850
-763
-17% -$64.1K 0.1% 99
2023
Q4 		$352K Buy
4,613
+546
+13% +$38K 0.1% 95
2023
Q3 		$282K Buy
4,067
+512
+14% +$41.1K 0.12% 95
2023
Q2 		$335K Buy
+3,555
New +$309K 0.13% 89

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Humankind Investments's EW Position: Q4 2025 in Review

Humankind Investments sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 7,248 shares — an estimated $564K sold.

Humankind Investments first reported a position in EW in Q2 2023 and held it in 10 quarters. The position peaked at $564K in Q3 2025. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • Humankind Investments reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 7,248 Edwards Lifesciences shares in Q4 2025, an estimated $564K.
  • Humankind Investments first reported a position in Edwards Lifesciences in Q2 2023 and held it in 10 quarters.
  • Humankind Investments's Edwards Lifesciences position peaked at $564K in Q3 2025.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.